OpenVSafe by OpenVAERS
Search V-safe

7X3-16130-49486

4 vaccinations 7 coded responses 45 check-ins 7 free-text entries 3 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
802 / CO
Registered
2021-01-09
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-20
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-09
    Registered in v-safe
  3. 2021-01-09
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-09
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-01-09
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-01-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-01-10
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  8. 2021-01-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  9. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-16
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-23
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-01-30
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-06
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-20
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-04-10
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-07-10
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-09-08
    Dose 3 — Pfizer-BioNTech
  21. 2021-09-08
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  22. 2021-09-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness · Headache
    Adult check-in
  23. 2021-09-10
    Survey response — days 1–6 daily, dose 3
    MedDRA: Axillary pain, Tenderness — Feeling: Good · Site: Pain, Redness, Swelling · Joint pains, Muscle or body aches
    Free text: Ipsilateral axillary pain and tenderness without any palpable axillary lymphadenopathy or swelling.
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-09-11
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy, Tenderness — Feeling: Good · Site: Pain, Redness, Itching
    Free text: Axillary lymphadenopathy and tenderness
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-09-12
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Redness
    Free text: Axillary lymphadenopathy and tenderness, mild
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-09-14
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  27. 2021-09-15
    Survey response — day 7, dose 3
    MedDRA: Dysuria, Urinary tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Systemic reaction (other): Dysuria · Healthcare visit (other): Given prescription for antibiotics for UTI
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-09-15
    Report sent to call center — day 7, dose 3
    Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-09-16
  30. 2021-09-21
  31. 2021-09-22
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-09-29
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-10-06
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-10-13
    Survey response — day 35, dose 3
    MedDRA: Pregnancy test positive — Feeling: Good
    Free text: Positive pregnancy test
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-10-20
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  36. 2021-12-08
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-03-09
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-09-08
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in
  39. 2022-09-30
    Dose 4 — Pfizer-BioNTech
  40. 2022-09-30
    Health check-in — day 0, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  41. 2022-10-01
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  42. 2022-10-02
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  43. 2022-10-03
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  44. 2022-10-04
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  45. 2022-10-05
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  46. 2022-10-06
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  47. 2022-10-07
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  48. 2022-10-14
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  49. 2022-10-21
    Survey response — day 21, dose 4
    MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair
    Free text: Developed some kind of cold over the last 5 days. Tested negative for Covid.
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-10-28
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  51. 2022-11-04
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  52. 2022-11-13
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  53. 2022-12-30
    Survey response — 3 months, dose 4
    MedDRA: Cholecystitis acute — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization
    Free text: Acute cholecystitis
    MedDRA releases: 2024-11 · check-in free text available
  54. 2022-12-30
    Report sent to call center — 3 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  55. 2023-01-04
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  56. 2023-01-04
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  57. 2023-03-31
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-20Pfizer-BioNTech
22021-01-09Pfizer-BioNTech
32021-09-08Pfizer-BioNTech No
42022-09-30Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-10 priority 2/3
2021-09-15 Successful
2023-01-04
 Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-12-30 Successful
2023-01-04
 Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 9 — days 1–6 daily, dose 3

2021-09-10

Systemic reaction (other): Ipsilateral axillary pain and tenderness without any palpable axillary lymphadenopathy or swelling.

2021-09-11

Systemic reaction (other): Axillary lymphadenopathy and tenderness

2021-09-12

Systemic reaction (other): Axillary lymphadenopathy and tenderness, mild

Release 9 — day 7, dose 3

2021-09-15

Systemic reaction (other): Dysuria
Healthcare visit (other): Given prescription for antibiotics for UTI

Release 10 — day 35, dose 3

2021-10-13

Symptoms: Positive pregnancy test

Release 12 — day 21, dose 4

2022-10-21

Symptoms: Developed some kind of cold over the last 5 days. Tested negative for Covid.

Release 12 — 3 months, dose 4

2022-12-30

Symptoms: Acute cholecystitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUrinary tract infection · · ✓
SDCholecystitis acute · · ✓
SDNasopharyngitis · · ✓
SDPregnancy test positive · · ✓
SDSARS-CoV-2 test negative · · ✓
SROAxillary pain · · ✓
SRODysuria · · ✓
SROLymph node pain · · ✓
SROLymphadenopathy · · ✓
SROTenderness · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…